Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,986.00 23.50 (1.20%)

Bid:

1,985.50

Ask:

1,986.50

Spread: 1.00 (0.05%)

Market Cap: £79.62b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK's Exdensur backed in Japan as asthma and rhinosinusitis treatment

(Alliance News) - GSK PLC on Tuesday said depemokimab, sold under the brand name Exdensur, has been approved by Japan's Ministry of Health, Labour and...

Japan approves GSK treatment for severe asthma

(Sharecast News) - GSK said Japan's Ministry of Health had approved its bronchial asthma treatment Exdensur after trial results showed "significant re...

GSK's Nucala backed in China for chronic obstructive pulmonary disease

(Alliance News) - GSK PLC on Monday said mepolizumab, sold under the brand name Nucala, has been approved in China for use in adults with chronic obst...

LONDON BRIEFING: Auction Technology rejects 11 FitzWalter buyout bids

(Alliance News) - Balfour Beatty sells ten UK assets for GBP87 million, Wizz Air and Ryanair report growth in passenger numbers for December, while Au...

GSK's COPD treatment approved by Chinese regulators

(Sharecast News) - Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled chronic...

UK dividends calendar - next 7 days

London's FTSE 100 closes lower in shortened Christmas Eve session

FTSE 100 down 0.2%; FTSE 250 ⁠down ‌0.07% *

LONDON MARKET CLOSE: FTSE fails to sparkle in tame pre-holiday trade

(Alliance News) - The FTSE 100 drifted lower on Wednesday in lacklustre trading ahead of the Christmas break, although a chunky disposal by BP brought...